Figure 1.
Cumulative incidence of 100-day grade II–Ⅳ aGVHD (A) and Ⅲ–Ⅳ aGVHD (B) after allo-HCT. allo-HCT, allogeneic hematopoietic cell transplantation; aGVHD, acute graft versus host disease.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.